Presynaptic GABAB receptors differentially modulate GABA release from cholecystokinin and parvalbumin interneurons onto CA1 pyramidal neurons: A cell type-specific labeling and activating study

Neurosci Lett. 2022 Feb 16:772:136448. doi: 10.1016/j.neulet.2022.136448. Epub 2022 Jan 10.

Abstract

Combining cell type-specific optogenetics and whole cell recordings on mouse acute hippocampal slices, we compared GABA release from cholecystokinin-expressing (CCK) and parvalbumin-expressing (PV) interneurons onto CA1 pyramidal neurons. Baclofen, a selective GABAB receptor agonist, inhibited GABAergic synaptic transmission greater from CCK terminals, compared to that from PV terminals. The N-type calcium channels on CCK and P/Q-type calcium channels on PV terminals contributed to the GABAB receptor-mediated inhibition, respectively. Our data thus provide direct evidence that GABAB receptors differentially modulate GABA release from CCK and PV interneurons, adding to an increasing list of differences between these two interneuron subtypes in modulating hippocampal pyramidal neurons.

Keywords: Cholecystokinin; GABA; GABA(B) receptors; Hippocampus; Optogenetics; Parvalbumin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CA1 Region, Hippocampal / cytology
  • CA1 Region, Hippocampal / metabolism*
  • Calcium Channels, N-Type / metabolism
  • Cells, Cultured
  • Cholecystokinin / genetics
  • Cholecystokinin / metabolism
  • Interneurons / metabolism*
  • Mice
  • Parvalbumins / genetics
  • Parvalbumins / metabolism
  • Pyramidal Cells / metabolism*
  • Receptors, GABA-B / metabolism*
  • gamma-Aminobutyric Acid / metabolism*

Substances

  • Calcium Channels, N-Type
  • Parvalbumins
  • Receptors, GABA-B
  • gamma-Aminobutyric Acid
  • Cholecystokinin